Stock Splits
By The Online Investor Staff, updated Mon., Feb. 6, 2:26 AM
| This Slide: #10 of 25 |
Slide #10. Alterity Therapeutics Limited (NASDAQ:ATHE) — 1 for 10 Reverse Split
Announced:
1/6/2023
Stock Split:
1 for 10
Record Date:
1/6/2023
Pay Date:
1/9/2023
ATHE Optionable?:
No
Alterity Therapeutics is a development stage enterprise engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological disorders. Co. is developing therapies to treat neurodegenerative diseases. Co.'s primary drug candidate, ATH434 is for treatment of Parkinson's disease. Other applications for Co.'s main compounds include the treatment or amelioration of neurodegenerative disorders such as tauopathies, Motor Neuron disease, Creutzfeldt-Jakob disease, certain cancers, age-related macular degeneration, or antibiotic resistance. 
ATHE Detailed Information Page & Split History »
|
|||||||||
Open the ATHE Page at The Online Investor (in a new window) »
 Free ATHE Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
